News

Exploring Veterinary Collaboration Opportunities at BioFIT 2025

Exploring Veterinary Collaboration Opportunities at BioFIT 2025

Can-Fite's Expanding Veterinary Pipeline at BioFIT 2025

As veterinary oncology continues to evolve, the potential of Namodenoson, a promising Phase III cancer drug, emerges as a topic of interest. The veterinary market size is projected to reach a substantial $3.1 billion by 2030, indicating a growing need for innovative treatment options in this field.

BioFIT 2025: A Platform for Veterinary Innovation

Can-Fite BioPharma Ltd. will showcase its veterinary initiatives at the upcoming BioFIT 2025 conference in Strasbourg, France. This event is a significant European gathering that showcases advances in life sciences, focusing on fostering partnerships and investment opportunities in biotechnology.

Success Stories Fueling New Opportunities

Reflecting on previous experiences, Can-Fite's participation at BioFIT has proven fruitful. The collaboration with Vetbiolix for Piclidenoson, developed to treat osteoarthritis in dogs and cats, exemplifies how these events can lead to valuable partnerships. This collaboration is projected to generate an estimated $325 million in royalty revenues for the company.

Namodenoson: A Promising Candidate for Veterinary Oncology

At BioFIT 2025, Can-Fite will aim to establish a second veterinary partnership focusing on Namodenoson. The drug has shown notable anti-tumor effectiveness and has a strong safety profile, making it an ideal candidate for treating various cancers in animals.

Engaging with Industry Leaders

During the event, Can-Fite plans to engage in discussions with major players in the animal health sector, including Elanco Animal Health and Zoetis. These meetings serve as a crucial platform to explore collaborative efforts aimed at advancing Namodenoson's veterinary development.

The Road Ahead for Can-Fite BioPharma Ltd.

Can-Fite BioPharma (NYSE: CANF, TASE: CANF.TA) is at the forefront of drug development targeting cancer and inflammatory diseases. The company’s innovative pipeline includes Namodenoson, currently in several clinical trials. This proactive approach positions Can-Fite to capitalize on lucrative markets in the healthcare space.

Innovative Molecules at the Heart of Development

Beyond Namodenoson, Can-Fite has seen success with Piclidenoson for psoriasis and is evaluating its other candidates such as CF602, which has shown effectiveness in treating erectile dysfunction. Each of these potential treatments highlights the company’s commitment to improving health outcomes.

Maintaining Safety Standards

With over 1,600 patients participating in clinical studies, Can-Fite prioritizes safety, ensuring that their treatments are both effective and well-tolerated. This commitment enhances their credibility in the biotech market.

Conclusion

As Can-Fite prepares for BioFIT 2025, it embodies the spirit of innovation and partnership in veterinary medicine. By pursuing new collaboration opportunities for Namodenoson, the company is set to make a significant impact in veterinary oncology, ultimately enhancing the quality of care available for our beloved pets.

Frequently Asked Questions

What is Namodenoson?

Namodenoson is a Phase III anti-cancer drug candidate being developed for both human and veterinary oncology, demonstrating efficacy against various tumors.

What is the focus of Can-Fite at BioFIT 2025?

Can-Fite aims to establish partnerships focused on the veterinary applications of Namodenoson and build upon previous successful collaborations.

Which companies will Can-Fite engage with during the conference?

Can-Fite plans to hold discussions with major animal health companies such as Elanco Animal Health and Zoetis during BioFIT 2025.

How does Can-Fite ensure the safety of its drug candidates?

Can-Fite has an excellent safety profile based on extensive clinical studies involving over 1,600 patients, ensuring their treatments are safe for ongoing development.

What is the projected growth of the veterinary oncology market?

The veterinary oncology market is projected to reach $3.1 billion by 2030, reflecting a significant opportunity for innovative treatments like Namodenoson.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Booming Door Market: $105.93B by 2031, Key Insights

Updated Category News Views 16

Introduction to the Future of the Door Industry Here's what gets me grinning—despite the market doomsayers, there's one industry that's swinging open new opportunities every year: doors. Projected to hit a whopping $105.93 billion by 2031, this market isn't just about hinges and handles. It's a sign of booming construction, urban development, and rising consumer...

Continue Reading
Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 87

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading
Jay Group Expands to Houston with New Fulfillment Hub

Updated Category News Views 67

Jay Group's Bold Move in the Logistics Arena In a no-holds-barred expansion, Jay Group's got themselves a brand new sprawling 250,000-square-foot fulfillment hub deep in the heart of Houston. Now, folks, this isn’t just another warehouse. We're talking a 3PL powerhouse that allows coast-to-coast delivery, hitting 90% of U.S. consumers in just a couple of days. If you're...

Continue Reading
Veralto Sees Strong Q3 2026 Growth, Eyes 2027 Gains

Updated Category News Views 22

Veralto's Stellar Third Quarter Performance Jumping right into the thick of it, Veralto's third quarter 2026 numbers aren't just a flash in the pan. We're talking a solid sales boost of 7.5%, reaching the magic number of $1,509 million. If you're holding NYSE:VLTO, these figures are a good look. It's not every day you see an operating profit margin hovered at an...

Continue Reading
Guidewire Celebrates P&C Insurance Innovators

Updated Category News Views 32

P&C Insurance Takes Center Stage If there's one thing that gets the blood pumping at a conference, it's innovation. This year, Guidewire pulled out all the stops at their Connections Conference in Las Vegas, spotlighting customer and partner triumphs in the P&C insurance sector. From Guidewire Innovation Awards to Partner Excellence Awards, the event was an ode to...

Continue Reading
LeWiz's NASA Contract: A Step Toward Stellar Networking

Updated Category News Views 32

Pioneering New Frontiers in Space Networking LeWiz Communications just snagged a shiny new NASA contract to tackle a challenge that's been a real thorn in space tech's side: reliable networking for spacecraft. That's right, while traditional Ethernet has been ruling the roost here on Earth, it doesn't quite cut it beyond our atmosphere. Aerospace systems demand precision,...

Continue Reading
EDB Enhances Postgres with Horizontal Scaling Preview

Updated Category News Views 57

EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...

Continue Reading
USD 6.8 Million for Disease R&D: GHIT's Bold Bet

Updated Category News Views 74

GHIT Fund Pumps Millions Into Health R&D In a world plagued by infectious disease outbreaks and continual health challenges, the Global Health Innovative Technology (GHIT) Fund isn't just twiddling its thumbs—they're throwing down around $6.8 million to wrestle some of the nastiest bugs out there, like malaria and Ebola. This cash doubles down on nine risky gambles,...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 41

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
Kansas City Life Welcomes Kellie Needham to Board

Updated Category News Views 39

A New Era in Kansas City Life's Leadership This ain't your run-of-the-mill board appointment, folks. Kansas City Life Insurance Company has just handed the reins to Kellie S. Needham, who steps in to fill her mother's recently vacated board seat. Imagine that—a family legacy stretching back to the early 1900s when J.B. Reynolds first laid the foundation. Legacy Unbroken...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Hounds Expands Franchise Opportunities for Dog Lovers

Updated Category News Views 196

Natural Hounds Expands Franchise Opportunities Across the Nation Fransmart Supports the Game-Changing Pet Brand Natural Hounds, a pioneering franchise in the world of fresh, locally-made dog food, is making significant strides to expand its franchise opportunities across the nation. This initiative comes in partnership with Fransmart, a global leader in franchise...

Continue Reading
KBC Group's Annual Capital Increase: What You Need to Know

Updated Category News Views 192

Understanding KBC Group's Annual Capital Increase KBC Group NV has a tradition of conducting an annual capital increase, specifically tailored for its staff. This initiative reflects the company’s commitment to engage and reward its employees, enhancing their financial security and investment in the organization. The Purpose of the Annual Capital Increase The annual...

Continue Reading
Challenges Loom for Ukrainian Gas Transit Amidst Tensions

Updated Category News Views 192

Challenges in Ukrainian Gas Transit Agreements The ongoing situation regarding the gas transit agreement through Ukraine has become increasingly tense. President Vladimir Putin recently remarked that due to the refusal of Ukraine to extend the existing agreement, there is no possibility of signing a new contract before the year ends. Putin's Remarks on Gas Supply Refusal...

Continue Reading
Great Southern Bancorp, Inc. Sees Increase in Q1 Earnings

Updated Category News Views 307

Overview of Great Southern Bancorp, Inc. Great Southern Bancorp, Inc. (NASDAQ:GSBC), a leading financial institution, has recently shared its preliminary earnings report for the first quarter of 2025. The firm has demonstrated a notable improvement in earnings compared to the previous year, reflecting its ongoing strength in the market. Financial Highlights for Q1 2025...

Continue Reading
REcore Solutions Sues Homes.com Over Contract Breach Issues

Updated Category News Views 389

REcore Solutions Legal Action Against Homes.com REcore Solutions LLC, the vendor responsible for licensing services for the Multiple Listing Service, has taken the significant step of filing a lawsuit against Homes.com and its parent company, CoStar Group, for breach of contract. This lawsuit arises out of a deep concern over the usage and compensation of MLS data....

Continue Reading